[Remote] Director, Pathology Services at Natera

United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, DiagnosticsIndustries

Requirements

MD/DO degree
ABP board-certified/eligible in AP/CP and Molecular
Completion of training relating to HIPAA/PHI privacy, General Policies and Procedure Compliance training, and security training within the first 30 days of hire
Maintain current status on Natera training requirements

Responsibilities

Provide clinical oversight of Natera’s laboratory pathology testing to ensure proper performance, regulatory standards compliance, accurate and reliable patient test results, and proper maintenance of the histology lab (FFPE tissue block processing, slide staining/coverslipping/scanning)
Perform performance evaluation of other pathologists in your report
Review patient specimens prior to testing in collaboration with other applicable stakeholders
Review clinical notes (e.g., chief complaint and treatment history) and pathology reports for tumor information (primary location, histologic type, sample location [primary vs metastatic]), perform tumor circling on H&E slides for molecular testing, and help identify alternative optimal FFPE block(s) and/or tumor specimen if the current sample is inadequate
Review and sign out Immunohistochemistry reports
Provide clinical and technical support for genetic counselors and other laboratory personnel
Set standards for laboratory testing and acceptable levels of analytic performance and ensure these are maintained
Analyze lab data and contribute to or write publications for high-quality scientific journals
May serve as Clinical Consultant, ensuring proper utility of assays (including sample selection and test appropriateness), test reports include pertinent information for test interpretation, and availability for consultation on test results and interpretation related to specific patient conditions
May serve as Technical Supervisor, ensuring appropriate test method selection; adequate method verification; enrollment in CMS-approved proficiency testing (PT) program; PT samples tested per CLIA requirements; PT results returned timely; PT reports reviewed; corrective actions for unacceptable PT results; quality assessment and control programs maintained; acceptable analytical performance established and maintained; remedial actions for deviations documented; patient results reported only when system functions properly; personnel trained and competent prior to testing; policies for monitoring personnel competency (preanalytic, analytic, post-analytic); remedial training provided; and approved procedure manual available
Manage a team, including reviewing/approving assigned work, mentoring/developing personnel, dedicated succession planning, and contingency management
Work with PHI in paper and electronic form and access various technologies to access PHI to perform the job

Skills

Key technologies and capabilities for this role

PathologyHistologyFFPE processingH&E slidesImmunohistochemistryTumor circlingMolecular testingLab oversightRegulatory complianceClinical consultationTechnical supervisionLab data analysis

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free